Dexmedetomidine and Sinus arrest - a phase IV clinical study of FDA data

Summary:

Sinus arrest is reported as a side effect among people who take Dexmedetomidine (dexmedetomidine hydrochloride), especially for people who are female, 0-1 old, have been taking the drug for < 1 month also take Midazolam, and have Sedation.

The phase IV clinical study analyzes which people have Sinus arrest when taking Dexmedetomidine. It is created by eHealthMe based on reports of 4,501 people who have side effects when taking Dexmedetomidine from the FDA, and is updated regularly.

What is Dexmedetomidine?

Dexmedetomidine has active ingredients of dexmedetomidine hydrochloride. eHealthMe is studying from 4,502 Dexmedetomidine users. Check the latest studies of Dexmedetomidine.

What is Sinus arrest?

Sinus arrest (sinus pause) is found to be associated with 205 drugs and 372 conditions by eHealthMe. Check the latest studies of Sinus arrest.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

4,501 people reported to have side effects when taking Dexmedetomidine.
Among them, 39 people (0.87%) have Sinus arrest.

Could Dexmedetomidine cause Sinus arrest?

Among these 39 people:

How long have people been on Dexmedetomidine when they have Sinus arrest? *

What is the gender of people who have Sinus arrest when taking Dexmedetomidine? *

female: 67.65 %
male: 32.35 %

What is the age of people who have Sinus arrest when taking Dexmedetomidine? *

What are other drugs people take besides Dexmedetomidine? *

Midazolam: 4 people, 10.26%
Fentanyl: 3 people, 7.69%
Piperacillin And Tazobactam: 2 people, 5.13%
Ceftriaxone: 2 people, 5.13%
Vancomycin: 1 person, 2.56%
Sertraline: 1 person, 2.56%
Senna: 1 person, 2.56%
Propofol: 1 person, 2.56%
Pantoprazole: 1 person, 2.56%
Mycostatin: 1 person, 2.56%

What are other side effects people have besides Sinus arrest? *

Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 17 people, 43.59%
Bradycardia (abnormally slow heart action): 14 people, 35.90%
Drug Clearance Decreased: 6 people, 15.38%
Bradyarrhythmia (heart slowness): 6 people, 15.38%
Cardiac Arrest: 6 people, 15.38%
Drug Level Increased: 6 people, 15.38%
Agitation (state of anxiety or nervous excitement): 6 people, 15.38%
Atrioventricular Block (heart block): 4 people, 10.26%
Electrocardiogram Qt Prolonged: 3 people, 7.69%
Overdose: 2 people, 5.13%

What are the existing conditions these people have? *

Sedation: 22 people, 56.41%
Anaesthesia: 6 people, 15.38%
Agitation (state of anxiety or nervous excitement): 6 people, 15.38%
Muscle Function Loss: 5 people, 12.82%
Hypotension (abnormally low blood pressure): 2 people, 5.13%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.13%
Arrhythmias (irregular heartbeat): 2 people, 5.13%
Respiratory Distress (difficulty in breathing): 1 person, 2.56%
Procedural Hypotension: 1 person, 2.56%
Hypotonia (low muscle tone): 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Dexmedetomidine and have Sinus arrest?

- Check whether Sinus arrest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dexmedetomidine:

Dexmedetomidine (4,502 reports)

Sinus arrest treatments and more:

Sinus arrest (2,017 reports)

Browse all side effects of Dexmedetomidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus arrest:

Sinus arrest (205 drugs)

Browse all the conditions that are associated with Sinus arrest:

Sinus arrest (372 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dexmedetomidine hydrochloride (the active ingredients of Dexmedetomidine) and Dexmedetomidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.